Researchers use nanoparticles to overcome treatment-resistant breast cancer
Researchers from the University of Cincinnati College of Medicine have developed RNA nanoparticles that show promise in overcoming treatment-resistant breast cancer. The team’s work was published in ACS Nano.
The researchers used a nanocarrier to target HER2-positive breast cancer and stop the production of a specific protein to prevent metastasis and render the cancer cells vulnerable to tamoxifen, a therapy for estrogen-driven cancer.
Get the full story at our sister site, Drug Delivery Business News.
The post Researchers use nanoparticles to overcome treatment-resistant breast cancer appeared first on MassDe...
Source: Mass Device - December 15, 2016 Category: Medical Equipment Authors: Sarah Faulkner Tags: Drug-Device Combinations Oncology Pharmaceuticals Research & Development University of Cincinnati Source Type: news
Breast cancer patients fail to complete tamoxifen therapy
Around 20% of breast cancer patients do not complete prescribed endocrine therapy, such as tamoxifen, according to researchers. (Source: Nursing Times)
Source: Nursing Times - December 14, 2016 Category: Nursing Source Type: news
Menopausal Symptoms Cut Tamoxifen Adherence (CME/CE)
(MedPage Today) -- Headaches and nausea/vomiting were particularly problematic (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - December 11, 2016 Category: Journals (General) Source Type: news
Tamoxifen may get blamed for unrelated symptoms
HealthDay News Some women who take tamoxifen to prevent breast cancer may mistake naturally occurring nausea and vomiting for side effects and stop taking it, a study finds. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 9, 2016 Category: Consumer Health News Source Type: news
Naturally occurring symptoms may be mistaken for tamoxifen side-effects
Women taking tamoxifen to prevent breast cancer were less likely to continue taking the drug if they suffered nausea and vomiting, according to new data. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 9, 2016 Category: Science Source Type: news
Tamoxifen May Get Blamed for Unrelated Symptoms
Perceived side effects might lead some to stop taking the breast cancer preventative, study finds (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - December 9, 2016 Category: Cancer & Oncology Authors: webmaster at doctorslounge.com Tags: Gynecology, Nursing, Oncology, Pharmacy, News, Source Type: news
Women wrongly stop taking breast cancer drug Tamoxifen because of 'side effects'
A Cancer Research UK study has found that women taking dummy drugs are just as likely to suffer nausea and vomiting as those taking tamoxifen, and are just as likely to stop taking them. (Source: the Mail online | Health)
Source: the Mail online | Health - December 9, 2016 Category: Consumer Health News Source Type: news
Tamoxifen May Get Blamed for Unrelated Symptoms
Perceived side effects might lead some to stop taking the breast cancer preventative, study finds (Source: WebMD Health)
Source: WebMD Health - December 9, 2016 Category: Consumer Health News Source Type: news
Symptoms may be ‘mistaken’ for tamoxifen side effects
Naturally occurring symptoms may be mistaken for side-effects of a common drug that may result in them wrongly stopping treatment, according to a UK study. (Source: Nursing Times)
Source: Nursing Times - December 9, 2016 Category: Nursing Source Type: news
Breast cancer drug: Cancer prevention pill Tamoxifen might NOT cause nasty side-effects
TAMOXIFEN is a hormone therapy for breast cancer which reduces the risk of the disease coming back after surgery. However, experts have revealed some women are stopping taking the drug because they mistakenly believe it is causing unpleasant side-effects, research has revealed. (Source: Daily Express - Health)
Source: Daily Express - Health - December 9, 2016 Category: Consumer Health News Source Type: news
Breast cancer drug update: Cancer prevention pill Tamoxifen may NOT cause side-effects
TAMOXIFEN is a hormone therapy for breast cancer which reduces the risk of the disease coming back after surgery. However, experts have revealed some women are stopping taking the drug because they mistakenly believe it is causing unpleasant side-effects, research has revealed. (Source: Daily Express - Health)
Source: Daily Express - Health - December 9, 2016 Category: Consumer Health News Source Type: news
Tamoxifen May Get Blamed for Unrelated Symptoms
FRIDAY, Dec. 9, 2016 -- Some high-risk women who take tamoxifen to prevent breast cancer may mistake naturally occurring nausea and vomiting for side effects of the drug and stop taking it, a new study finds.
Previous research has shown that taking... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 9, 2016 Category: Journals (General) Source Type: news
Tamoxifen May Get Blamed for Unrelated Symptoms
Title: Tamoxifen May Get Blamed for Unrelated SymptomsCategory: Health NewsCreated: 12/9/2016 12:00:00 AMLast Editorial Review: 12/9/2016 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - December 9, 2016 Category: Cancer & Oncology Source Type: news
Naturally occurring symptoms may be mistaken for tamoxifen side-effects
(Cancer Research UK) Women taking tamoxifen to prevent breast cancer were less likely to continue taking the drug if they suffered nausea and vomiting, according to new data presented at the San Antonio Breast Cancer Symposium. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 9, 2016 Category: Global & Universal Source Type: news
Advance by UCLA scientists could shed light on cell that may contribute to ALS and Alzheimer ’s
An achievement by UCLA neuroscientists could lead to a better understanding of astrocytes, a type of cell in the brain that is thought to play a role in Lou Gehrig ’s disease, also called amyotrophic lateral sclerosis, or ALS; Alzheimer’s disease; Huntington’s disease; and other neurological disorders.The researchers are the first to have bred mice in which an artificial gene called Cre/ERT2, a basic tool for studying the functions of cells, can be activated exclusively in astrocytes. A paper describing their work waspublished online today in the journal Neuron.Neuroscientists have been trying for years to engine...
Source: UCLA Newsroom: Health Sciences - December 9, 2016 Category: Universities & Medical Training Source Type: news
